William I. Bensinger, MD
Dr. Bensinger treats patients with blood disorders, lymphoma, multiple myeloma, and myelodysplastic syndrome.Patient Care Philosophy:
I think it is important to understand patients' needs and goals during the management of their disease. Once I understand this, I feel I am better able to suggest appropriate therapies designed to minimize symptoms and achieve their wishes. Above all I value a patient's autonomy with regard to the management of their illness; the patient has to undergo any proposed treatments and thus must have the last word with regard to therapy choices.
Title
- Director, Autologous Marrow Transplant Program, Seattle Cancer Care Alliance
- Member, Clinical Research Division, Fred Hutchinson Cancer Research Center
- Professor of Medicine, University of Washington School of Medicine
Clinical Expertise
Autologous Stem Cell Transplantation, Targeted Radiotherapy, Immunotherapy
Education And Training
- Northwestern University, 1973
More Information
For more information about Dr. William I. Bensinger's clinical and research expertise, click here.
Clinical Trials
- Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (2434)
- Lenalidomide + Bortezomib + Dexamethasone for Multiple Myeloma (2477)
- BHQ880 for High Risk Smoldering Multiple Myeloma (2482)
- Yttrium Y 90 anti-CD45 monoclonal antibody BC8 + Chemo + TDI before Transplant for Multiple Myeloma (2450)

Join Us On